Description
Parkinson et parkinsonismes
- About pregnancy in Parkinson's disease
J Parkinsons Dis. 2026 Feb 18:1877718X251413026. doi: 10.1177/1877718X251413026. Online ahead of print.NO ABSTRACTPMID:41707246 | DOI:10.1177/1877718X251413026
- Towards Automated Analysis of Gaze Behavior from Consumer VR Devices for Neurological Diagnosis
Pac Symp Biocomput. 2026;31:219-235. doi: 10.1142/9789819824755_0016.ABSTRACTRecent studies have demonstrated that eye tracking is a valuable tool in the detection, classification and staging of […]
- Trustworthy AI for medical decisions: Adversarially robust and fair machine learning prediction for Parkinson's disease
PLoS One. 2026 Feb 23;21(2):e0342062. doi: 10.1371/journal.pone.0342062. eCollection 2026.ABSTRACTParkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor […]
- Recommendations to Improve Healthcare Service Provision for Cognitive Impairment in People With Parkinson's Disease: A Mixed Methods Study of the Lived Experience Expert Perspective
Health Expect. 2026 Apr;29(2):e70530. doi: 10.1111/hex.70530.ABSTRACTBACKGROUND: Cognitive impairment, including dementia, is one of the most important nonmotor symptoms of Parkinson's disease (PD). […]
- Cell-autonomous and noncell-autonomous drivers of dopamine neuron vulnerability in Parkinson's disease
Trends Neurosci. 2026 Mar 12:S0166-2236(26)00027-5. doi: 10.1016/j.tins.2026.02.003. Online ahead of print.ABSTRACTThe motor symptoms of Parkinson's disease are linked to age-dependent degeneration […]
- Investigating the Genetic Relationship Between Vitamin B12 Metabolism and Parkinson Disease
Neurol Genet. 2026 Feb 16;12(2):e200350. doi: 10.1212/NXG.0000000000200350. eCollection 2026 Apr.ABSTRACTBACKGROUND AND OBJECTIVES: Epidemiologic studies suggest that patients with Parkinson disease […]
- Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score
Mov Disord. 2026 Feb 17. doi: 10.1002/mds.70231. Online ahead of print.ABSTRACTParkinson's disease (PD) risk and progression are influenced by a complex interplay of genetic, environmental, and […]
- Creation of a machine learning-based model for early identification of mild cognitive impairment risk in Parkinson's disease: A PD research center-based population study
J Parkinsons Dis. 2026 Mar 11:1877718X261424696. doi: 10.1177/1877718X261424696. Online ahead of print.ABSTRACTBackgroundThis study aimed to use data from the PD-MDCNC database to develop a risk […]
- Early bone health assessment is indicated in Parkinson's: Risk factor analysis in a UK population-based cohort study
J Parkinsons Dis. 2026 Mar 11:1877718X261429758. doi: 10.1177/1877718X261429758. Online ahead of print.ABSTRACTBackgroundOsteoporosis and major osteoporotic fracture are more common in PD than […]
- A modified Delphi consensus study to support and enhance Parkinson's disease management
J Parkinsons Dis. 2026 Mar 9:1877718X261427577. doi: 10.1177/1877718X261427577. Online ahead of print.ABSTRACTBackgroundLevodopa is still the cornerstone of symptomatic treatment for people with […]
Traitements pharmacologiques
Médicaments
- Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment
Z Gerontol Geriatr. 2026 Feb 19. doi: 10.1007/s00391-026-02558-1. Online ahead of print.ABSTRACTLevodopa in combination with a decarboxylase inhibitor has an elimination half-life (t1/2) in older […]
- Quantifying the Tolerability of Dopamine Agonist Antiparkinsonian Medication Side Effects: A Best-Worst Scaling Survey
Patient Prefer Adherence. 2026 Feb 24;20:570840. doi: 10.2147/PPA.S570840. eCollection 2026.ABSTRACTPURPOSE: To identify dopamine agonist (DA) medication side effects that people with Parkinson's […]
- Glycosylation Matters: Network Pharmacology-Based and Molecular Docking Analysis of Resveratrol Glycosylated Derivatives on Parkinson's Disease
ACS Omega. 2026 Jan 23;11(5):7597-7615. doi: 10.1021/acsomega.5c08887. eCollection 2026 Feb 10.ABSTRACTResveratrol (RV), a natural polyphenol, has been extensively studied for its neuroprotective […]
- An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine
Ageing Res Rev. 2026 Feb 25:103070. doi: 10.1016/j.arr.2026.103070. Online ahead of print.ABSTRACTParkinson's disease (PD) is a complex neurodegenerative disorder with both genetic and environmental […]
- Advancing personalized medicine for Parkinson's disease: transforming treatment and therapeutic outcomes
3 Biotech. 2026 Apr;16(4):127. doi: 10.1007/s13205-025-04674-y. Epub 2026 Mar 9.ABSTRACTThe emergence of personalized medicine represents a significant change in medicine and offers more accurate and […]
Études cliniques phase 3 et phase 4
- Breaking the Barrier of Brain Disease Therapeutics: Advocating Targeted Drug Delivery for Improved Neuro-Resident Interventions
AAPS PharmSciTech. 2026 Mar 4;27(3):128. doi: 10.1208/s12249-026-03386-7.ABSTRACTThis paper provides an expert review of extant research into commercially utilized targeted drug delivery systems for […]
- Quantifying Slowness in Parkinson Disease Using a Serious Game: Cross-Sectional Study
JMIR Serious Games. 2026 Feb 25;14:e79463. doi: 10.2196/79463.ABSTRACTBACKGROUND: Slowness in voluntary movements is a hallmark of Parkinson disease (PD); yet, objective measurement outside clinical […]
- Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease
J Neurol. 2026 Feb 18;273(2):151. doi: 10.1007/s00415-026-13683-7.ABSTRACTINTRODUCTION: Genetic studies have identified the GBA1 gene as a significant genetic risk factor for Parkinson's disease […]
Traitements non pharmacologiques
Chirurgie
- Non-invasive brain stimulation for treating cognitive and neuropsychiatric non-motor symptoms in Parkinson's disease and atypical parkinsonism: a systematic review and meta-analysis of randomized controlled trials
J Neural Transm (Vienna). 2026 Mar 5. doi: 10.1007/s00702-026-03127-x. Online ahead of print.NO ABSTRACTPMID:41784828 | DOI:10.1007/s00702-026-03127-x
- Genotype-associated outcomes after deep brain stimulation in Parkinson's disease: a systematic review, meta-analysis and epigenetic implications
Neurol Neurochir Pol. 2026 Mar 13. doi: 10.5603/pjnns.110289. Online ahead of print.ABSTRACTINTRODUCTION: Deep brain stimulation (DBS) is an established treatment for advanced Parkinson's disease […]
- Deep brain stimulation beyond Motor control: A systematic review and meta-analysis of sleep outcomes in Parkinson's disease
Parkinsonism Relat Disord. 2026 Feb 13:108237. doi: 10.1016/j.parkreldis.2026.108237. Online ahead of print.ABSTRACTDeep brain stimulation (DBS) has been a major advancement in treating movement […]
- When caution becomes neglect: Deep brain stimulation and cognitive impairment in Parkinson's disease
J Parkinsons Dis. 2026 Feb 27:1877718X261428282. doi: 10.1177/1877718X261428282. Online ahead of print.ABSTRACTOver the past 25 years, a prevailing clinical dogma has held that significant cognitive […]
- Development and acceptability of a deep brain stimulation surgery decision aid for Parkinson's disease
J Parkinsons Dis. 2026 Feb 18:1877718X261425106. doi: 10.1177/1877718X261425106. Online ahead of print.ABSTRACTBackgroundThe decision to undergo deep brain stimulation (DBS) surgery for patients with […]
Approches multidisciplinaires
- Effect evaluation of the positive emotion, engagement, relationships, meaning, and accomplishment (PERMA) positive psychological intervention model in patients with Parkinson's disease
Neuropsychology. 2026 Feb;40(2):216-227. doi: 10.1037/neu0001047.ABSTRACTOBJECTIVE: This study aimed to evaluate the effects of positive psychological intervention based on the Positive Emotion, […]
- The influence of visual input and attention on gait initiation in people with Parkinson disease
PLoS One. 2026 Feb 18;21(2):e0342661. doi: 10.1371/journal.pone.0342661. eCollection 2026.ABSTRACTINTRODUCTION: Gait initiation relies on the integration of postural control, sensory input, and […]
- Post-rehabilitation self-management support on physical activity and nutrition, including mHealth, improves physical capacity, physical activity, and health related quality of life in people with Parkinson's- results from a randomised controlled trial
Int J Behav Nutr Phys Act. 2026 Feb 17. doi: 10.1186/s12966-026-01888-y. Online ahead of print.NO ABSTRACTPMID:41703544 | DOI:10.1186/s12966-026-01888-y
- Efficacy of a social robot-assisted training for socio-cognitive and cognitive functions in Parkinson's disease: A comparison with an active control group
Asian J Psychiatr. 2026 Feb 11;118:104885. doi: 10.1016/j.ajp.2026.104885. Online ahead of print.ABSTRACTThis study evaluated the efficacy of 12-week of Socially Assistive Robot (SAR) training […]
Thérapies alternatives
- Seeking Traditional Health Practitioners and Use of Complementary/Alternative Medicines in the Management of Movement Disorders in Africa: A Multicenter Continental Study
Mov Disord. 2026 Mar 15. doi: 10.1002/mds.70280. Online ahead of print.ABSTRACTBACKGROUND: Traditional health practitioners (THP) and complementary and alternative medicines (CAM) play a […]
- Parkinson's disease and voluntary walking interventions - a systematic review and meta-analysis
Arch Phys Med Rehabil. 2026 Jan 31:S0003-9993(26)00048-1. doi: 10.1016/j.apmr.2026.01.024. Online ahead of print.ABSTRACTOBJECTIVE: The primary objective was to quantify the effect of interventions […]
Qualité de vie des patients
- Empowering Patients: The Role of Group Health Coaching in Improving Self-Efficacy and Well-Being in Parkinson's Disease
Am J Lifestyle Med. 2026 Mar 9:15598276261430282. doi: 10.1177/15598276261430282. Online ahead of print.ABSTRACTPURPOSE: This study investigated the impact of a novel group health coaching curriculum […]
- Longitudinal evidence of technology-enhanced, individualized neuromotor rehabilitation on autonomy, cognition, quality of life, and psychological well-being: Pilot multi-sample study
PLoS One. 2026 Mar 13;21(3):e0344472. doi: 10.1371/journal.pone.0344472. eCollection 2026.ABSTRACTBACKGROUND: Over the last decades, neuromotor rehabilitation programs have integrated […]
- Multivariate analysis of sex differences in Parkinson's disease: the distinct contributions of fall-related self-efficacy and voice handicap
Neurodegener Dis Manag. 2026 Mar 16:1-7. doi: 10.1080/17582024.2026.2645615. Online ahead of print.ABSTRACTBACKGROUND: Sex-related differences in Parkinson's disease (PD) have been frequently […]
- The structure of personality in Parkinson's disease and the effects of age, years since diagnosis, and impulsivity
PeerJ. 2026 Feb 19;14:e20725. doi: 10.7717/peerj.20725. eCollection 2026.ABSTRACTBACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor and […]
- The experience of caregivers of patients affected by Parkinson's who have undergone deep brain stimulation
Br J Nurs. 2026 Mar 5;35(5):264-270. doi: 10.12968/bjon.2025.0003. Epub 2026 Mar 5.ABSTRACTBACKGROUND: Parkinson's is a neurodegenerative condition that has a critical impact on every aspect of the […]
Technologies de soutien
- In-person when necessary and available, remotely when possible - How telemedicine can support palliative care for persons with Parkinson's disease: a qualitative study
BMC Palliat Care. 2026 Feb 23. doi: 10.1186/s12904-026-02002-6. Online ahead of print.ABSTRACTBACKGROUND: Essential components of optimal palliative care for people with Parkinson's disease (PD) […]
- Wearable sensor measurements in relation to clinical characteristics and mortality in patients with Parkinson's disease
Neurol Res Pract. 2026 Mar 11;8(1):14. doi: 10.1186/s42466-026-00474-8.NO ABSTRACTPMID:41814450 | DOI:10.1186/s42466-026-00474-8
- The Effects of Digital Health Interventions on Motor Symptoms, Nonmotor Symptoms, and Quality of Life in Patients With Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials
J Med Internet Res. 2026 Mar 12;28:e79935. doi: 10.2196/79935.ABSTRACTBACKGROUND: Parkinson disease (PD) is a progressive neurodegenerative disorder with increasing global prevalence, necessitating […]
- Technologies used in Parkinson's disease: a meta-analysis of their effect on health-related quality of life
J Neurol. 2026 Mar 12;273(3):203. doi: 10.1007/s00415-026-13749-6.ABSTRACTOBJECTIVE: The results of randomised controlled trials (RCTs) and meta-analyses in the literature on whether technologies […]
- New smartphone platform helps doctors track Parkinson’s symptoms
The integration of Kneu Health’s smartphone-based platform into Cedars-Sinai’s Parkinson’s care program enabled ongoing symptom monitoring and revealed the need for earlier intervention in 79% […]
- Telerehabilitation for early-stage Parkinson's disease: A randomized controlled feasibility trial of individualised real-time physiotherapy delivered via a videoconference platform
J Parkinsons Dis. 2026 Feb 20:1877718X261418551. doi: 10.1177/1877718X261418551. Online ahead of print.ABSTRACTIntroductionExercise can improve outcomes for people with Parkinson's. […]
Associations et ordres professionnels
Québec
- Photos from Parkinson Québec's poston 17 mars 2026
🧬 Nouvelle rubrique scientifique : Les syndromes parkinsoniens secondaires ou atypiques : comprendre les maladies apparentées Bon à savoir pour agir efficacement ! Le […]
- Photos from Parkinson Québec's poston 17 mars 2026
Le Fortinet Face-off frappe encore fort au Centre Bell.🏒 Dans ce lieu emblématique, Fortinet et sa communauté de partenaires ont une fois de plus démontré que l’impact dépasse largement […]
- 🎥 L’expert répond - Dysphagie et Parkinson : mieux reconnaître, mieux s’adapteron 17 mars 2026
🎥 L’expert répond - Dysphagie et Parkinson : mieux reconnaître, mieux s’adapter La dysphagie, un trouble de la déglutition, peut avoir un impact important sur l’alimentation, la santé […]
- Les différents stades de la maladie de Parkinson : comprendre l’évolutionon 17 mars 2026
Comment la maladie de Parkinson progresse-t-elle au fil du temps ? Quels sont les symptômes et défis associés à chaque stade ? Dans ce webinaire, la Dre Élaine Racine-Charette, neurologue […]
- Avancées en recherche 🧠Maladie de Parkinsonon 17 mars 2026
Avancées en recherche 🧠Maladie de Parkinson L’équipe d’Alexandra Potvin-Desrochers, chercheuse au CISSS de l’Outaouais, vient de publier un article scientifique portant sur […]
- 💧 Maladie de Parkinson et transpiration excessive : votre expérience compteon 17 mars 2026
💧 Maladie de Parkinson et transpiration excessive : votre expérience compte Vous vivez avec la maladie de Parkinson et vous transpirez beaucoup plus qu’avant… ou au contraire, pas du tout? […]
- La neurostimulation non invasive pour ralentir le déclin fonctionnel dans la maladie de Parkinsonon 17 mars 2026
Notre webinaire scientifique « La neurostimulation non invasive pour ralentir le déclin fonctionnel dans la maladie de Parkinson » est en ligne sur notre chaîne YouTube! Le Dr Cyril Schneider […]
Canada
- Je pensais être trop jeune, et trop femme, pour avoir la maladie de Parkinsonon 17 mars 2026
Avant de recevoir mon diagnostic de la maladie de Parkinson, je croyais à tort qu’elle touchait principalement une population beaucoup plus âgée et majoritairement masculine. J’ai appris que […]
- Les lacunes systémiques dans la maladie de Parkinson chez les femmeson 17 mars 2026
Depuis des décennies, l’image publique de la maladie de Parkinson a été largement façonnée par la manière dont elle se manifeste chez les hommes. Mais la maladie de Parkinson […]
- Le Japon accorde une approbation conditionnelle et limitée à une thérapie basée sur les cellules souches pour la maladie de Parkinsonon 17 mars 2026
Une thérapie basée sur les cellules souches pour le traitement des symptômes moteurs de la maladie de Parkinson, AMCHEPRY® (raguneprocel), a reçu une approbation conditionnelle et limitée pour […]
- « Mon traitement fonctionne jusqu’à ce que mes règles commencent » : l’histoire de Lion 17 mars 2026
Quand on pense à l’apparence d’une personne atteinte de la maladie de Parkinson, la plupart des gens concluent qu’il s’agit d’un homme blanc âgé. Mais la maladie de Parkinson ne se […]
- Le Parkinson, c’est plus que ce que l’on voit à l’extérieuron 17 mars 2026
Quand les gens entendent le mot « Parkinson », ils pensent aux tremblements, à la raideur, à la lenteur – tous des symptômes moteurs visibles. Mais la maladie de Parkinson ne se résume pas à […]
- Better access to care through CARE Fundon 17 mars 2026
New programs for underserved communities across Canada View this email in your browser Have you heard of CARE Fund? It’s an […]
- Women with Parkinson's must be heardon 17 mars 2026
Listen to women's stories. Create change. View this email in your browser Women with Parkinson's matterThe experiences of women […]
- A newly updated resource for care partnerson 6 mars 2026
Care Partnering: Managing Parkinson¿s together, is available now View this email in your browser Care partners need support, too. […]
États-Unis
- New imaging shows how exercise helps ‘normalize’ the Parkinson’s brainon 17 mars 2026
Six months of regular aerobic exercise can partially “normalize” disrupted brain communication in people with Parkinson’s disease, a new Canadian study suggests. By cycling for an hour three […]
- US, China regulators OK trials of stem cell therapy in MSA-Pon 17 mars 2026
Regulators in the U.S. and China have granted Xellsmart permission to start clinical testing of its experimental stem cell therapy in people with multiple system atrophy-Parkinsonian type (MSA-P). […]
- The invisible support a Parkinson’s caregiver provideson 17 mars 2026
One thing I learned quickly as a caregiver is that much of the work happens where no one else can see it. Most people think of caregiving in clear, visible ways. They imagine helping someone stand, […]
- Immunis plans Phase 1 trial of treatment for Parkinson’s dyskinesiaon 17 mars 2026
Immunis said it entered into an exclusive deal with Toray for the rights to develop and commercialize a potential treatment for dyskinesia, the involuntary movements associated with long-term use of […]
- Your March Newsworthy Notes Newsletter has arrived!on 17 mars 2026
Newsworthy Notes - March 2026 Download March Newsletter EXECUTIVE DIRECTOR'S MESSAGE This month, Executive Director Eileen Lynch honors the legacy of PRO board member Michael Opell — a […]
- Science News: Treating Sleep Apnea May Lower Parkinson's Riskon 17 mars 2026
CPAP use linked to reduced risk of […]
- Science News: Orthostatic Hypotension in PD Raises Fall Riskon 17 mars 2026
Fall risk > cardiovascular events […]
- New Resources for Living Well With Parkinson'son 17 mars 2026
View this message on our website. Living well with Parkinson’s is shaped by both expert knowledge and the experiences of people navigating it every day. TOMORROW STARTS […]
- New Webinar: Inside the Science - Parkinson's Research Todayon 17 mars 2026
Plus, sign up for our AI & PD webinar… […]
- Parkinson’s Perspectives: Living with Young Onset Parkinson’son 17 mars 2026
Perspectives from People with YOPD At the American Parkinson Disease Association (APDA), we know that some of the most powerful insights about Parkinson’s disease (PD) come from the people […]
International
- Les chiens qui détectent les maladies : comment leur odorat dépasse toutes nos machines – Comité 17on 17 mars 2026
Les chiens qui détectent les maladies : comment leur odorat dépasse toutes nos machines – Comité 17 Dans le journal « 20 minutes », un article trés intéressant […]
- Podcast: Women and Parkinson’s – closing the gender gapon 17 mars 2026
This special podcast episode for International Women’s Day 2026 explores the unique experiences of women with Parkinson’s The post Podcast: Women and Parkinson’s – closing the gender gap […]
- 15 expert-approved tips to manage swallowing problems in Parkinson’son 17 mars 2026
Eating and swallowing problems are common in Parkinson’s. It can be frustrating when these challenges get in the way of enjoying the things you usually love, like meals with family and friends. […]
- Tips to help you manage drooling when you have Parkinson’son 16 mars 2026
Many people with Parkinson’s experience problems with saliva control, which can lead to drooling or dribbling. We produce an average of 1.5 litres of saliva a day and normally we swallow this […]
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


